Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma

A Large Cohort Analysis

Won Ki Lee, Sung Kyu Hong, Sangchul Lee, Cheol Kwak, Jong Jin Oh, Chang Wook Jeong, Yong June Kim, Seok Ho Kang, Sung Hoo Hong, Seok Soo Byun

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In 2769 patients with nonmetastatic renal cell carcinoma (RCC), the prognostic value of body mass index (BMI) according to histologic subtype was assessed. Increased BMI was associated with increased survival in clear cell RCC and decreased survival in chromophobe RCC, and not associated in papillary RCC. The association between BMI and RCC prognosis may differ by histologic subtype. Objective: The objective of our study was to assess the prognostic value of body mass index (BMI) according to histologic subtype in nonmetastatic renal cell carcinoma (RCC), based on a large multicenter experience. Methods: A total of 2769 patients with nonmetastatic RCC at the time of surgery were enrolled from 5 Korean institutions between 1999 and 2011. BMI was used as a continuous variable and was categorized according to the World Health Organization recommendation for Asians into normal weight (≥ 18.5 and < 23 kg/m2) and overweight and obese (≥ 23 kg/m2). Results: In patients with clear cell variant, increased BMI was associated with higher recurrence-free survival (RFS) or cancer-specific survival (CSS) rates by multivariate analyses (hazard ratio [HR] of RFS, 0.940; P =.007; HR of CSS, 0.875; P <.001). On the other hand, increased BMI in patients with chromophobe variant was associated with lower RFS or CSS rates, unlike in patients with clear cell variant (HR of RFS, 1.317, P =.011; HR of CSS, 1.320; P =.031). In patients with papillary variant, BMI was not associated with RFS or CSS (P >.05 for each). Conclusions: Our results showed that increased BMI was a favorable prognostic factor in patients with clear cell variant. However, increased BMI was a poor prognostic factor in patients with chromophobe variant and was not associated with prognosis in those with papillary variant. Our study suggests that the association between BMI and RCC prognosis may differ by histologic subtype.

Original languageEnglish
Pages (from-to)461-468
Number of pages8
JournalClinical Genitourinary Cancer
Volume13
Issue number5
DOIs
Publication statusPublished - 2015 Oct 1

Fingerprint

Renal Cell Carcinoma
Body Mass Index
Cohort Studies
Survival
Weights and Measures

Keywords

  • Body mass index
  • Histology
  • Obesity
  • Renal cell carcinoma
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma : A Large Cohort Analysis. / Lee, Won Ki; Hong, Sung Kyu; Lee, Sangchul; Kwak, Cheol; Oh, Jong Jin; Jeong, Chang Wook; Kim, Yong June; Kang, Seok Ho; Hong, Sung Hoo; Byun, Seok Soo.

In: Clinical Genitourinary Cancer, Vol. 13, No. 5, 01.10.2015, p. 461-468.

Research output: Contribution to journalArticle

Lee, Won Ki ; Hong, Sung Kyu ; Lee, Sangchul ; Kwak, Cheol ; Oh, Jong Jin ; Jeong, Chang Wook ; Kim, Yong June ; Kang, Seok Ho ; Hong, Sung Hoo ; Byun, Seok Soo. / Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma : A Large Cohort Analysis. In: Clinical Genitourinary Cancer. 2015 ; Vol. 13, No. 5. pp. 461-468.
@article{59f84854fc7a4120a2a7935893e5ad96,
title = "Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma: A Large Cohort Analysis",
abstract = "In 2769 patients with nonmetastatic renal cell carcinoma (RCC), the prognostic value of body mass index (BMI) according to histologic subtype was assessed. Increased BMI was associated with increased survival in clear cell RCC and decreased survival in chromophobe RCC, and not associated in papillary RCC. The association between BMI and RCC prognosis may differ by histologic subtype. Objective: The objective of our study was to assess the prognostic value of body mass index (BMI) according to histologic subtype in nonmetastatic renal cell carcinoma (RCC), based on a large multicenter experience. Methods: A total of 2769 patients with nonmetastatic RCC at the time of surgery were enrolled from 5 Korean institutions between 1999 and 2011. BMI was used as a continuous variable and was categorized according to the World Health Organization recommendation for Asians into normal weight (≥ 18.5 and < 23 kg/m2) and overweight and obese (≥ 23 kg/m2). Results: In patients with clear cell variant, increased BMI was associated with higher recurrence-free survival (RFS) or cancer-specific survival (CSS) rates by multivariate analyses (hazard ratio [HR] of RFS, 0.940; P =.007; HR of CSS, 0.875; P <.001). On the other hand, increased BMI in patients with chromophobe variant was associated with lower RFS or CSS rates, unlike in patients with clear cell variant (HR of RFS, 1.317, P =.011; HR of CSS, 1.320; P =.031). In patients with papillary variant, BMI was not associated with RFS or CSS (P >.05 for each). Conclusions: Our results showed that increased BMI was a favorable prognostic factor in patients with clear cell variant. However, increased BMI was a poor prognostic factor in patients with chromophobe variant and was not associated with prognosis in those with papillary variant. Our study suggests that the association between BMI and RCC prognosis may differ by histologic subtype.",
keywords = "Body mass index, Histology, Obesity, Renal cell carcinoma, Survival",
author = "Lee, {Won Ki} and Hong, {Sung Kyu} and Sangchul Lee and Cheol Kwak and Oh, {Jong Jin} and Jeong, {Chang Wook} and Kim, {Yong June} and Kang, {Seok Ho} and Hong, {Sung Hoo} and Byun, {Seok Soo}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.clgc.2015.04.012",
language = "English",
volume = "13",
pages = "461--468",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma

T2 - A Large Cohort Analysis

AU - Lee, Won Ki

AU - Hong, Sung Kyu

AU - Lee, Sangchul

AU - Kwak, Cheol

AU - Oh, Jong Jin

AU - Jeong, Chang Wook

AU - Kim, Yong June

AU - Kang, Seok Ho

AU - Hong, Sung Hoo

AU - Byun, Seok Soo

PY - 2015/10/1

Y1 - 2015/10/1

N2 - In 2769 patients with nonmetastatic renal cell carcinoma (RCC), the prognostic value of body mass index (BMI) according to histologic subtype was assessed. Increased BMI was associated with increased survival in clear cell RCC and decreased survival in chromophobe RCC, and not associated in papillary RCC. The association between BMI and RCC prognosis may differ by histologic subtype. Objective: The objective of our study was to assess the prognostic value of body mass index (BMI) according to histologic subtype in nonmetastatic renal cell carcinoma (RCC), based on a large multicenter experience. Methods: A total of 2769 patients with nonmetastatic RCC at the time of surgery were enrolled from 5 Korean institutions between 1999 and 2011. BMI was used as a continuous variable and was categorized according to the World Health Organization recommendation for Asians into normal weight (≥ 18.5 and < 23 kg/m2) and overweight and obese (≥ 23 kg/m2). Results: In patients with clear cell variant, increased BMI was associated with higher recurrence-free survival (RFS) or cancer-specific survival (CSS) rates by multivariate analyses (hazard ratio [HR] of RFS, 0.940; P =.007; HR of CSS, 0.875; P <.001). On the other hand, increased BMI in patients with chromophobe variant was associated with lower RFS or CSS rates, unlike in patients with clear cell variant (HR of RFS, 1.317, P =.011; HR of CSS, 1.320; P =.031). In patients with papillary variant, BMI was not associated with RFS or CSS (P >.05 for each). Conclusions: Our results showed that increased BMI was a favorable prognostic factor in patients with clear cell variant. However, increased BMI was a poor prognostic factor in patients with chromophobe variant and was not associated with prognosis in those with papillary variant. Our study suggests that the association between BMI and RCC prognosis may differ by histologic subtype.

AB - In 2769 patients with nonmetastatic renal cell carcinoma (RCC), the prognostic value of body mass index (BMI) according to histologic subtype was assessed. Increased BMI was associated with increased survival in clear cell RCC and decreased survival in chromophobe RCC, and not associated in papillary RCC. The association between BMI and RCC prognosis may differ by histologic subtype. Objective: The objective of our study was to assess the prognostic value of body mass index (BMI) according to histologic subtype in nonmetastatic renal cell carcinoma (RCC), based on a large multicenter experience. Methods: A total of 2769 patients with nonmetastatic RCC at the time of surgery were enrolled from 5 Korean institutions between 1999 and 2011. BMI was used as a continuous variable and was categorized according to the World Health Organization recommendation for Asians into normal weight (≥ 18.5 and < 23 kg/m2) and overweight and obese (≥ 23 kg/m2). Results: In patients with clear cell variant, increased BMI was associated with higher recurrence-free survival (RFS) or cancer-specific survival (CSS) rates by multivariate analyses (hazard ratio [HR] of RFS, 0.940; P =.007; HR of CSS, 0.875; P <.001). On the other hand, increased BMI in patients with chromophobe variant was associated with lower RFS or CSS rates, unlike in patients with clear cell variant (HR of RFS, 1.317, P =.011; HR of CSS, 1.320; P =.031). In patients with papillary variant, BMI was not associated with RFS or CSS (P >.05 for each). Conclusions: Our results showed that increased BMI was a favorable prognostic factor in patients with clear cell variant. However, increased BMI was a poor prognostic factor in patients with chromophobe variant and was not associated with prognosis in those with papillary variant. Our study suggests that the association between BMI and RCC prognosis may differ by histologic subtype.

KW - Body mass index

KW - Histology

KW - Obesity

KW - Renal cell carcinoma

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84941601103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941601103&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2015.04.012

DO - 10.1016/j.clgc.2015.04.012

M3 - Article

VL - 13

SP - 461

EP - 468

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 5

ER -